Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac vs. Bromfenac in Cataract Patients
NCT00469690Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketorolac, bromfenac sodium in cataract, sponsored by Janssen Pharmaceutical. Started May 2007; status: completed.
02
Drugs
ketorolacbromfenac sodium
03
Conditions
cataract
Beyond the preview
Go deeper on NCT00469690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469690.